Biotech firm ImmuCell reports big revenue boost for Q3
The company said it has eliminated a production bottleneck that restricted sales in 2018 despite increased customer demand. |!| Portland
The company said it has eliminated a production bottleneck that restricted sales in 2018 despite increased customer demand. |!| Portland